V024-3175 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-{[1-ethyl-2-oxo-4-(propan-2-yl)-1,2-dihydroquinolin-7-yl]oxy}acetamide

V024-3175 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-{[1-ethyl-2-oxo-4-(propan-2-yl)-1,2-dihydroquinolin-7-yl]oxy}acetamide
V024-3175 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-{[1-ethyl-2-oxo-4-(propan-2-yl)-1,2-dihydroquinolin-7-yl]oxy}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V024-3175
N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-{[1-ethyl-2-oxo-4-(propan-2-yl)-1,2-dihydroquinolin-7-yl]oxy}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V024-3175

Molecular Formula

C24H26N2O5 (C24 H26 N2 O5)

Compound Name

N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-{[1-ethyl-2-oxo-4-(propan-2-yl)-1,2-dihydroquinolin-7-yl]oxy}acetamide

IUPAC name

N-[(2H-13-benzodioxol-5-yl)methyl]-2-{[1-ethyl-2-oxo-4-(propan-2-yl)-12-dihydroquinolin-7-yl]oxy}acetamide

SMILES

CCN(c(cc(cc1)OCC(NCc(cc2)cc3c2OCO3)=O)c1C(C(C)C)=C1)C1=O

InChI

InChI=1S/C24H26N2O5/c1-4-26-20-10-17(6-7-18(20)19(15(2)3)11-24(26)28)29-13-23(27)25-12-16-5-8-21-22(9-16)31-14-30-21/h5-11,15H,4,12-14H2,1-3H3,(H,25,27)

InChI Key

CYHNNYAZTUDEDE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14284795

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

422.48

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.944

Distribution Coefficient, logD

3.944

Water Solubility, LogSw

-4.07

Polar Surface Area

64.430

Acid Dissociation Constant (pKa)

14.66

Base Dissociation Constant (pKb)

-0.65

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

V024-3175 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V024-3175 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V024-3175?
Check Price and Availability of V024-3175, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V024-3175 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V024-3175
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V024-3175
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V024-3175 available by request